Rubiés-Prat J - Search Results

1

Relationship between lipoprotein profile and urinary albumin excretion in type II diabetic patients with stable metabolic control.

Reverter JL, Sentí M, Rubiés-Prat J, Lucas A, Salinas I, Pizarro E, Pedro-Botet J, Romero R, Sanmartí A. Reverter JL, et al. Diabetes Care. 1994 Mar;17(3):189-94. doi: 10.2337/diacare.17.3.189. Diabetes Care. 1994. PMID: 8174446

2

Calculated low-density lipoprotein cholesterol should not be used for management of lipoprotein abnormalities in patients with diabetes mellitus.

Rubiés-Prat J, Reverter JL, Sentí M, Pedro-Botet J, Salinas I, Lucas A, Nogués X, Sanmartí A. Rubiés-Prat J, et al. Diabetes Care. 1993 Aug;16(8):1081-6. doi: 10.2337/diacare.16.8.1081. Diabetes Care. 1993. PMID: 8375237

3

Lipoprotein composition in the insulin-deficient non-acidotic phase of type I diabetic patients and early evolution after the start of insulin therapy.

Reverter JL, Sentí M, Rubiés-Prat J, Lucas A, Salinas I, Pizarro E, Pedro-Botet J, Sanmartí A. Reverter JL, et al. Clin Chim Acta. 1993 Dec 31;223(1-2):113-20. doi: 10.1016/0009-8981(93)90067-e. Clin Chim Acta. 1993. PMID: 8143357

4

Secondary prevention of coronary heart disease in patients with extracoronary atherosclerosis: a need for accuracy of low density lipoprotein determination.

Sentí M, Pedro-Botet J, Rubiés-Prat J, Vidal-Barraquer F. Sentí M, et al. Angiology. 1996 Mar;47(3):241-6. doi: 10.1177/000331979604700304. Angiology. 1996. PMID: 8638866

5

When to treat dyslipidaemia of patients with chronic renal failure on haemodialysis? A need to define specific guidelines.

Pedro-Botet J, Senti M, Rubiés-Prat J, Pelegrí A, Romero R. Pedro-Botet J, et al. Nephrol Dial Transplant. 1996 Feb;11(2):308-13. doi: 10.1093/oxfordjournals.ndt.a027258. Nephrol Dial Transplant. 1996. PMID: 8671784

6

Thrombomodulin and induced tissue factor expression on monocytes as markers of diabetic microangiopathy: a prospective study on hemostasis and lipoproteins in insulin-dependent diabetes mellitus.

Reverter JL, Reverter JC, Tàssies D, Rius F, Monteagudo J, Rubiés-Prat J, Escolar G, Ordinas A, Sanmarti A. Reverter JL, et al. Am J Hematol. 1997 Oct;56(2):93-9. doi: 10.1002/(sici)1096-8652(199710)56:2<93::aid-ajh4>3.0.co;2-w. Am J Hematol. 1997. PMID: 9326350 Free article.

7

Effect of bezafibrate on lipoprotein (a) and triglyceride-rich lipoproteins, including intermediate-density lipoproteins, in patients with chronic renal failure receiving haemodialysis.

Pelegrí A, Romero R, Sentí M, Nogués X, Pedro-Botet J, Rubiés-Prat J. Pelegrí A, et al. Nephrol Dial Transplant. 1992;7(7):623-6. doi: 10.1093/ndt/7.7.623. Nephrol Dial Transplant. 1992. PMID: 1323073

8

Lipoprotein profile in men with peripheral vascular disease. Role of intermediate density lipoproteins and apoprotein E phenotypes.

Sentí M, Nogués X, Pedro-Botet J, Rubiés-Prat J, Vidal-Barraquer F. Sentí M, et al. Circulation. 1992 Jan;85(1):30-6. doi: 10.1161/01.cir.85.1.30. Circulation. 1992. PMID: 1728461

9

High density lipoprotein subfractions and physical activity: changes after moderate and heavy exercise training.

Fernández-Pardo J, Rubiés-Prat J, Pedro-Botet J, Terrer C, López MD, Sentí M, Nogués X. Fernández-Pardo J, et al. Rev Esp Fisiol. 1991 Dec;47(4):181-6. Rev Esp Fisiol. 1991. PMID: 1812540

10

Serum lipoprotein (a) levels in men with peripheral vascular disease.

Nogués X, Sentí M, Pedro-Botet J, Rubiés-Prat J, Vidal-Barraquer F. Nogués X, et al. Angiology. 1991 Aug;42(8):659-64. doi: 10.1177/000331979104200809. Angiology. 1991. PMID: 1832526

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

172 results

Search Page

Filters